Trials / Completed
CompletedNCT00234988
A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
Safety and Weight Reduction of Sibutramine in the Treatment of Thai Obese and Overweight Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine the safety and weight loss when sibutramine is used in overweight and obese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sibutramine hydochloride monohydrate | 10 mg QD with the option to increase dose to 15 mg QD up until Week 4 |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2006-01-01
- First posted
- 2005-10-10
- Last updated
- 2008-07-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00234988. Inclusion in this directory is not an endorsement.